ARAV Aravive Inc

3,179

$0.1387

$0.0049

(3.41%)

Today

Watchers	3,179
52-Wk Low	$0.1104
52-Wk High	$2.46

Market Cap	$10.2M
Volume (M)	1.24M
52-Wk High	$2.46
52-Wk Low	$0.1104

Fundamentals

Aravive, Inc. (NASDAQ:ARAV) Sees Significant Growth in Short InterestZolmax • 6 days ago

Aravive, Inc. (NASDAQ:ARAV Get Free Report) saw a large increase in short interest in August. As of August 31st, there was short interest totalling 4,480,000 shares, an increase of 21.4...

Share to Feed

Aravive, Inc. (NASDAQ:ARAV) Receives $10.17 Average Target Price from AnalystsZolmax • 23 days ago

Aravive, Inc. (NASDAQ:ARAV Get Free Report) has received a consensus rating of Hold from the six analysts that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the ...

Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group?PR Newswire • 23 days ago

Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group? Thinking about buying stock in Noco Noco, Inspire Veterinary Partners, Genius Group, Aravive Inc, or Cronos Group? PR Newswire NEW YORK, Aug. 31, 2023 NEW YORK, Aug. 31, 2023...

Investors Purchase Large Volume of Call Options on Aravive (NASDAQ:ARAV)Zolmax • 24 days ago

Aravive, Inc. (NASDAQ:ARAV Get Free Report) saw some unusual options trading on Monday. Traders purchased 2,997 call options on the company. This is an increase of approximately 322% compared to the average volume of 710 call options. Analysts Set New Price Targets A number of equities ...

Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI?PR Newswire • 26 days ago

Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI? Thinking about buying stock in Genius Group, Scilex Holding, Crown Electrokinetics, Aravive, or VERSES AI? PR Newswire NEW YORK, Aug. 28, 2023 NEW YORK, Aug. 28, 2023 /PRNewswire...

Aravive, Inc. (NASDAQ:ARAV) to Post Q3 2023 Earnings of ($0.16) Per Share, William Blair ForecastsTicker Report • 30 days ago

Aravive, Inc. (NASDAQ:ARAV Free Report) Research analysts at William Blair boosted their Q3 2023 earnings estimates for shares of Aravive in a note issued to investors on Tuesday, August 22nd. William Blair analyst A. Hsieh now anticipates that the company will post earnings of ($0....

Aravive (NASDAQ:ARAV) Cut to Neutral at Cantor FitzgeraldZolmax • 30 days ago

Aravive (NASDAQ:ARAV Get Free Report) was downgraded by Cantor Fitzgerald from an overweight rating to a neutral rating in a research report issued on Tuesday, Marketbeat reports. Several other brokerages have also recently weighed in on ARAV. William Blair cut Aravive from an outperform rating to a...

Analyst Downgrades Aravive: Grapples With Trial Setback, Strategic AlternativesBenzinga • about 1 month ago

Monday,Aravive Inc(NASDAQ: ARAV)filedits quarterly 10Q Latest Ratings for ARAV DateFirmActionFromTo Mar 2021BTIGInitiates Coverage OnBuy Sep 2020William BlairInitiates Coverage OnOutperform Jul 2020HC Wainwright & Co.MaintainsBuy View More Analyst Ratings for ARAV View the Latest Analyst ...

Cantor cuts Aravive to neutral as biotech struggles to stay in businessSeekingAlpha.com: All News • about 1 month ago

Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive?PR Newswire • about 1 month ago

Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive? Thinking about buying stock in T2 Biosystems, Oppfi, American Lithium, Zynerba Pharmaceuticals, or Aravive? PR Newswire NEW YORK, Aug. 15, 2023 NEW YORK, Aug. 15, 2023 /PRNewswire...